Hohberger Bettina, Welge-Lüen Ulrich-Christoph, Lämmer Robert
Department of Ophthalmology and Eye Clinic, Universitätsklinikum Erlangen, Friedrich-Alexander University, Erlangen-Nürnberg (FAU), Erlangen, Germany.
J Glaucoma. 2017 Feb;26(2):e103-e104. doi: 10.1097/IJG.0000000000000584.
Treatment of glaucoma eyes with iridocorneal endothelial syndrome is complex. Minimally invasive glaucoma surgery, such as one that implements a novel, microinvasive device, known as Xen gel stents, has shown promise in surgical glaucoma treatment and offers a new therapeutic option.
This is a case report.
A successful implantation of Xen45 gel stent in a woman with secondary glaucoma due to unilateral iridocorneal endothelial syndrome after descement membrane endothelial keratoplasty operation, and the follow-up are presented.
Implantation of Xen gel stents may be a promising option for minimally invasive glaucoma surgery in difficult situations, as low adverse effects, good postsurgery visual acuity and sufficient regulation of intraocular pressure can be seen.
治疗伴有虹膜角膜内皮综合征的青光眼病情复杂。微创青光眼手术,比如采用一种名为Xen凝胶支架的新型微创装置进行的手术,已在青光眼手术治疗中展现出前景,并提供了一种新的治疗选择。
这是一篇病例报告。
报告了一位因单侧虹膜角膜内皮综合征继发青光眼的女性患者,在施行后弹力层内皮角膜移植术后成功植入Xen45凝胶支架并进行随访的情况。
在困难情况下,植入Xen凝胶支架可能是微创青光眼手术的一个有前景的选择,因为其不良反应低、术后视力良好且眼压调节充分。